Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NTLA
INTELLIA THERAPEUTICS, INC.
NASDAQ
$12.87
▼ DOWN 1.83% (-0.24)

KEY STATISTICS

Market Cap$1.80 B
52w High$28.25
52w Low$7.95
Dividend Yield—
Frequency—
P/E-3.83
Volume3.44M
Shares Out.139.72M

COMPANY

LEADERSHIP

John Leonard
CHIEF EXECUTIVE
John Leonard

COMPENSATION 2026

Salary$708,000
Stock Awards$2,443,920
Incentive Plan Pay$0
All Other Comp.$26,429
Total$5,063,899

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 6, 2016
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
377

PRICE TARGET

Target High$49.00
Target Low$9.00
Target Median$20.50
Target Consensus$23.40

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$10.23M
NOV
5
THU

PRICE

$12.87 ▼ DOWN 1.83% (−$0.24)
$12.75$13.00$13.25$13.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM12.87

About Intellia Therapeutics, Inc.

https://www.intelliatx.com ↗

Intellia Therapeutics is a Cambridge-based genome editing company developing in vivo and ex vivo CRISPR-based therapeutics for various genetic, oncological, and autoimmune diseases through collaborations with major biotech firms.

INDUSTRY

Biotechnology

A PRODUCT INTELLIA THERAPEUTICS, INC. IS KNOWN FOR

Lonvoguran Ziclumeran (NTLA-2002)
Lonvoguran Ziclumeran (NTLA-2002)

An investigational CRISPR gene editing therapy in late-stage trials aims to provide a potential lifelong cure for hereditary angioedema by permanently inactivating the disease-causing gene.

COMPETITORS

COMPETITOR
BEAM COMPARE
CRBU COMPARE
CRSP COMPARE
EDIT COMPARE
VRTX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
165
LISTED HERE
26
RANKED BY POSITION SIZE
ARKK
1.92% · 9.7M
XBI
0.67% · 6.1M
VTI
0.00% · 4.3M
XSU.TO
0.06% · 3.5M
SCHA
0.04% · 668.7K
FESM
0.11% · 569.5K
FYC
0.41% · 449.0K
DFMC
0.06% · 388.6K
PRFZ
0.15% · 325.0K
LABU
0.46% · 222.5K
AVSC
0.09% · 212.6K
XRSU.L
0.06% · 123.6K
FSCC
0.33% · 87.9K
GNOM
1.10% · 80.0K
BBSC
0.07% · 38.2K
BBC
0.65% · 25.9K
GINN
0.10% · 15.7K
NIXT
0.41% · 13.7K
HRTS
0.32% · 13.7K
MEDX
0.85% · 11.4K
ETLZ.DE
0.07% · 11.2K
WDNA.L
0.36% · 9.2K
URTY
0.02% · 5.5K
RFLR
0.06% · 4.4K
TILT
0.00% · 3.2K
VETS
0.13% · 3.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
72.50%
HOLDERS
482
TOP 12 OF 482 · RANKED BY POSITION SIZE
Ark Investment Management LLC
16.9M sh · $285.54M
Blackrock, Inc.
15.4M sh · $260.72M
Vanguard Group Inc
13.0M sh · $116.96M
Blackrock Inc.
9.6M sh · $214.79M
State Street Corp
9.2M sh · $156.26M
D. E. Shaw & Co., Inc.
6.4M sh · $109.02M
Morgan Stanley
6.0M sh · $104.01M
Contrarius Group Holdings Ltd
5.9M sh · $101.72M
Two Sigma Investments, LP
5.2M sh · $88.58M
Fmr LLC
4.8M sh · $80.76M
Ra Capital Management, L.P.
4.5M sh · $76.6M
Goldman Sachs Group Inc
4.3M sh · $73.89M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score2

TRADES BY CONGRESS

SENATE TRADES
Thomas R. Carper
Thomas R. Carper
Sale (Full)
2023-08-25
HOUSE TRADES
Donald Sternoff Beyer
Donald Sternoff Beyer
Sale (Full)
2022-02-28
 Donald Sternoff Beyer Jr.
Donald Sternoff Beyer Jr.
Sale (Full)
2022-02-28
SENATE TRADES
James Inhofe
James Inhofe
Sale (Full)
2018-10-25

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT AND CEO
LEONARD JOHN M
Sale · 19.9K shares
2026-08-20
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
LEONARD JOHN M
Sale · 2.8K shares
2026-08-21
★
OFFICER: EVP, CHIEF FINANCIAL OFFICER
Dulac Edward J III
Sale · 8.1K shares
2026-07-22
★
OFFICER: VP, CHIEF ACCOUNTING OFFICER
Dube Michael P
Sale · 2.6K shares
2026-07-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
MARKET OUTPERFORM 2
OUTPERFORM 2
NEUTRAL 2
EQUAL WEIGHT 2
UNDERPERFORM 1
MARKET PERFORM 1
SELL 1
SECTOR PERFORM 1
OVERWEIGHT 1
UNDERWEIGHT 1
20 GRADES IN THE LAST 12 MONTHS
Citizens MARKET OUTPERFORM Evercore ISI Group OUTPERFORM Wolfe Research UNDERPERFORM Wedbush NEUTRAL Canaccord Genuity BUY HC Wainwright & Co. BUY Bernstein MARKET PERFORM Morgan Stanley EQUAL WEIGHT

SECTORS PEERS

PEERPRICE
SYRE$90.36COMPARE
IMNM$27.57COMPARE
BCRX$9.82COMPARE
PHVS$35.32COMPARE
BHVN$15.41COMPARE
ZYME$28.27COMPARE
STOK$31.62COMPARE
ZBIO$31.27COMPARE